Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Lilly's entry in San Diego to bolster the local biotechnology ecosystem
Date 01 October 2025

Lilly's entry in San Diego to bolster the local biotechnology ecosystem

Image Credit: PharmaVoice Announcement Eli Lilly and Company inaugurates the new Lilly Gateway Labs (LGL) site in San Diego, California. The company is extending its reach of shared innovation hub...

Femasys to strengthen its footprint in Europe by partnering with Kebomed
Date 30 September 2025

Femasys to strengthen its footprint in Europe by partnering with Kebomed

Image Credit: Femasys Inc. Announcement Femasys Inc., a known biomedical innovator making accessible fertility and non-surgical permanent birth control, and has been cost-effective to the women's ...

PepGen confirmed its proposed public offering
Date 29 September 2025

PepGen confirmed its proposed public offering

Image Credit: Oxford University Innovation Announcement Pepgen Inc., a leading clinical-level biotechnology company advancing the next generation future of oligonucleotide therapies with a motive ...

Lilly plans to expand its facility in Texas
Date 26 September 2025

Lilly plans to expand its facility in Texas

Announcement Eli Lilly and Company intends to build a new manufacturing facility worth $6.5 billion at the Generation Park in Houston, Texas. This intensification of the future synthetic medicine act...

Patient Square Capital Finalizes Business Deal
Date 25 September 2025

Patient Square Capital Finalizes Business Deal

Image Credit: AInvest Announcement Patient Square Capital, an affiliate of an investment firm, acquired healthcare firm Premier with a finalized deal value of approximately $2.6 billion. Patient S...

Psychedelic Recovery with AbbVie's Acquisition
Date 24 September 2025

Psychedelic Recovery with AbbVie's Acquisition

Image Credits: MSN Announcement Due to AbbVie’s $1.2 billion acquisition of Gilgamesh Pharmaceuticals' known depression drug, the psychedelic therapeutics revived from lykos rejection last...

Sunflower Therapeutics' First Milestone Payment through a Partnership with SK Bioscience
Date 23 September 2025

Sunflower Therapeutics' First Milestone Payment through a Partnership with SK Bioscience

Announcement The Sunflower Therapeutics, a known public-oriented corporation transitioning global access to protein manufacturing potential for different applications, showed the receipt of its fir...

Crown Bioscience's New Model Development Center in Kannapolis, North Carolina
Date 22 September 2025

Crown Bioscience's New Model Development Center in Kannapolis, North Carolina

Image Credits: Via Ritzau Announcement The Crown Bioscience, a leading contract research organization (CRO) headquartered in the United States and a significant part of JSR Life Sciences and Japan...

Bionano Calculated the Pricing of its Public Offering
Date 19 September 2025

Bionano Calculated the Pricing of its Public Offering

Image Credits: Guru Focus  Announcement Bionano Genomics, Inc., fixed the pricing of $10 million of a public offering of a total of 5,000,000 shares of the company’s common stock, serie...

Avidity Declared the Closing of the PO of Common Stock and More
Date 18 September 2025

Avidity Declared the Closing of the PO of Common Stock and More

Announcement Avidity biosciences inc, a leading biopharmaceutical company dedicated to provide a new class of RNA therapeutics known as antibody oligonucleotide conjugates (AOCs) have closed its la...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.